ѻý

New Cardiology Board to Come; 2nd Pig-Heart Xenotransplant; Uric Acid as Stroke Tx?

<ѻý class="mpt-content-deck">— Recent developments of interest in cardiovascular medicine
MedpageToday
Cardio Break over a computer rendering of a heart.

The American College of Cardiology said it is working to create an with the Heart Failure Society of America, Heart Rhythm Society, and Society for Cardiovascular Angiography & Interventions.

The University of Maryland team that performed the first cardiac xenotransplant last year announced that a has been performed on a patient who was ineligible for a traditional transplant.

Early , assessed by lung ultrasound, had prognostic value in some heart attack patients. (Heart)

Myocardial changes were observed on advanced nuclear imaging in people who . (Radiology)

Coronary calcium on can help with preoperative clinical risk stratification before noncardiac surgery. (Circulation)

Mirabegron (Myrbetriq), a β3-adrenergic receptor agonist developed for overactive bladder disease, had among patients with pre- or mild heart failure. (JAMA Cardiology)

may play a causal role in cardiovascular disease based on a Mendelian randomization analysis. (European Heart Journal)

The DEVI and CARPREG-II risk calculators showed clinical utility for . (Journal of the American College of Cardiology)

correlated with excess risk of major cardiovascular events in middle age. (Annals of Internal Medicine)

A global study showed that vary by sex and region. (Canadian Journal of Cardiology)

all separately contributed to a person's risk of myocardial infarction in Denmark. (European Journal of Preventive Cardiology)

Compared with a supervised treadmill exercise program, boosted 6-minute walk distance in patients with peripheral artery disease, a meta-analysis showed. (JAMA Network Open)

Positive topline results from a phase III trial were seen with in familial chylomicronemia syndrome, a rare genetic disorder also known as familial hypertriglyceridemia, Ionis Pharmaceuticals announced.

A treatment strategy targeting LDL cholesterol to a goal of 50-70 mg/dL was comparable to fixed high-intensity statin treatment for 3-year , regardless of diabetes status, in the LODESTAR trial. (eClinicalMedicine)

Could reduce ischemic brain injury in stroke survivors? A rodent study suggests this may be the case. (Science Translational Medicine)

  • author['full_name']

    Nicole Lou is a reporter for ѻý, where she covers cardiology news and other developments in medicine.